What is all the hoopla about?
If you can't see it, then you shouldn't be investing in bio stocks in the first place. for one, it makes the company much more desirable as a buyout target.
lets say there was a buyout within the next year or so...what do you think the pps would b..just a hypothetical?
future revenue...revenue...this is just one more way that acur is going to create future revenue combined with other products in the pipeline, like nexafed.
Sentiment: Strong Buy
I thought the statment was prior to that date